PBM Business Practices Come Under Greater Scrutiny

<p>New research and a new federal investigation are turning up the heat on PBMs and their role in high drug prices. Will anything come of it for consumers? We talked about it on today's episode of the 4sight Friday Roundup podcast.</p> <p>David Johnson is CEO of 4sight Health.</p> <p>Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.</p> <p>David Burda is News Editor and Columnist of 4sight Health.</p>